Briviact

Chemical Namebrivaracetam
Dosage FormTablet (oral; 10 mg, 25 mg, 50 mg, 75 mg, 100 mg); Solution (oral; 10 mg/mL); Injection (intravenous; 50 mg/ 5 mL)
Drug ClassAnticonvulsants
SystemNervous
CompanyUCB Inc.
Approval Year2016

Indication

  • To treat partial onset seizures in patients age 16 years and older with epilepsy.
Last updated on 10/22/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Briviact (brivaracetam) Prescribing Information 2019UCB, Inc., Smyrna, GA